229 related articles for article (PubMed ID: 35393108)
1. Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States.
Price MJ; Slotwiner D; Du C; Freeman JV; Turi Z; Rammohan C; Kusumoto FM; Kavinsky C; Akar J; Varosy PD; Koutras C; Curtis JP; Masoudi FA
JACC Cardiovasc Interv; 2022 Apr; 15(7):741-750. PubMed ID: 35393108
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry.
Price MJ; Valderrábano M; Zimmerman S; Friedman DJ; Kar S; Curtis JP; Masoudi FA; Freeman JV
Circ Cardiovasc Interv; 2022 May; 15(5):e011718. PubMed ID: 35369701
[TBL] [Abstract][Full Text] [Related]
4. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.
Daimee UA; Wang Y; Masoudi FA; Varosy PD; Friedman DJ; Du C; Koutras C; Reddy VY; Saw J; Price MJ; Kusumoto FM; Curtis JP; Freeman JV
Circ Cardiovasc Qual Outcomes; 2022 Aug; 15(8):e008418. PubMed ID: 35959677
[TBL] [Abstract][Full Text] [Related]
5. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
7. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
[TBL] [Abstract][Full Text] [Related]
8. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
[TBL] [Abstract][Full Text] [Related]
9. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation.
Kapadia SR; Krishnaswamy A; Whisenant B; Potluri S; Iyer V; Aragon J; Gideon P; Strote J; Leonardi R; Agarwal H; Larrain G; Sanchez C; Panaich SS; Harvey J; Vahl T; Menon V; Wolski K; Wang Q; Leon MB
Circulation; 2024 Mar; 149(10):734-743. PubMed ID: 37874908
[TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.
Paitazoglou C; Eitel I; Stiermaier T; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Vireca E; Wohlmuth P; Lucas B; Bergmann MW;
Catheter Cardiovasc Interv; 2023 Aug; 102(2):283-292. PubMed ID: 37393575
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry.
Betts TR; Leo M; Panikker S; Kanagaratnam P; Koa-Wing M; Davies DW; Hildick-Smith D; Wynne DG; Ormerod O; Segal OR; Chow AW; Todd D; Cabrera Gomez S; Kirkwood GJ; Fox D; Pepper C; Foran J; Wong T
Catheter Cardiovasc Interv; 2017 Feb; 89(3):484-492. PubMed ID: 27651124
[TBL] [Abstract][Full Text] [Related]
12. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
[TBL] [Abstract][Full Text] [Related]
13. The NCDR Left Atrial Appendage Occlusion Registry.
Freeman JV; Varosy P; Price MJ; Slotwiner D; Kusumoto FM; Rammohan C; Kavinsky CJ; Turi ZG; Akar J; Koutras C; Curtis JP; Masoudi FA
J Am Coll Cardiol; 2020 Apr; 75(13):1503-1518. PubMed ID: 32238316
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries.
Wang W; Chen LY; Walker RF; Alonso A; Norby FL; Lakshminarayan K; Lutsey PL
Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5786. PubMed ID: 38565524
[TBL] [Abstract][Full Text] [Related]
15. Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation.
Lin KJ; Singer DE; Avorn J; Heist EK; Sreedhara SK; Anand P; Zhang Y; Tsacogianis TN; Schneeweiss S
Circ Cardiovasc Qual Outcomes; 2024 Mar; 17(3):e010279. PubMed ID: 38440888
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation.
Noseworthy PA; Van Houten HK; Krumholz HM; Kent DM; Abraham NS; Graff-Radford J; Alkhouli M; Henk HJ; Shah ND; Gersh BJ; Friedman PA; Holmes DR; Yao X
J Am Heart Assoc; 2022 Oct; 11(19):e027001. PubMed ID: 36172961
[TBL] [Abstract][Full Text] [Related]
17. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China.
Su F; Gao C; Liu J; Ning Z; He B; Liu Y; Xu Y; Yang B; Li Y; Zhang J; Zhao X; Zhang Y; Hu H; Du X; Xie R; Zhou L; Zeng J; Ruan Z; Liu H; Guo J; Wang R; Garg S; Soliman O; Holmes DR; Serruys PW; Tao L
JAMA Netw Open; 2022 May; 5(5):e2214594. PubMed ID: 35639378
[TBL] [Abstract][Full Text] [Related]
19. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
[TBL] [Abstract][Full Text] [Related]
20. Impact of the CHA
Agudelo V; Millán X; Li CH; Asmarats L; Fernández-Peregrina E; Santaló M; Jimenez-Kockar M; Gheorghe L; Serra A; Arzamendi D
Int J Cardiol; 2020 Nov; 319():78-84. PubMed ID: 32634500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
